Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Nov 07, 2023 | Sale | $12.65 | 382 | 4,832 | 124,511 | Nov 08, 2023, 04:22 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Sep 01, 2023 | Sale | $21.82 | 273 | 5,956 | 124,893 | Sep 05, 2023, 04:23 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Jun 30, 2023 | Option Exercise | $35.28 | 367 | 12,948 | 125,166 | Jul 06, 2023, 04:14 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 03, 2023 | Sale | $76.16 | 21,421 | 1,631,411 | 144,650 | Mar 07, 2023, 04:52 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 02, 2023 | Sale | $75.28 | 937 | 70,535 | 99,038 | Mar 06, 2023, 04:41 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Growth Officer | Mar 01, 2023 | Sale | $76.36 | 1,923 | 146,845 | 99,975 | Mar 02, 2023, 05:00 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jan 05, 2023 | Sale | $108.00 | 387 | 41,796 | 82,843 | Jan 09, 2023, 06:20 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 02, 2022 | Sale | $79.04 | 269 | 21,261 | 83,230 | Sep 06, 2022, 05:12 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 05, 2022 | Option Exercise | $59.08 | 312 | 18,431 | 83,499 | Jul 07, 2022, 05:45 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 31, 2021 | Option Exercise | $154.01 | 3,717 | 572,455 | 85,625 | Mar 11, 2022, 04:54 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 09, 2022 | Sale | $71.19 | 3,669 | 261,196 | 83,187 | Mar 11, 2022, 04:54 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 07, 2022 | Sale | $69.55 | 5,294 | 368,198 | 84,389 | Mar 09, 2022, 04:56 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 08, 2022 | Sale | $70.10 | 2,481 | 173,918 | 81,908 | Mar 09, 2022, 04:56 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 03, 2022 | Sale | $74.50 | 997 | 74,275 | 94,229 | Mar 07, 2022, 06:23 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 04, 2022 | Sale | $72.11 | 4,546 | 327,790 | 91,597 | Mar 07, 2022, 06:23 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 03, 2021 | Sale | $138.68 | 501 | 69,477 | 73,692 | Sep 07, 2021, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 02, 2021 | Sale | $138.23 | 156 | 21,564 | 74,013 | Sep 07, 2021, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 04, 2021 | Sale | $148.71 | 2,063 | 306,789 | 74,169 | Aug 06, 2021, 04:41 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 03, 2021 | Sale | $149.43 | 1,654 | 247,157 | 76,232 | Aug 04, 2021, 05:09 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 06, 2021 | Option Exercise | $137.12 | 154 | 21,117 | 77,886 | Jul 08, 2021, 05:29 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jun 10, 2021 | Sale | $215.00 | 23,540 | 5,061,100 | 77,732 | Jun 11, 2021, 04:26 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 08, 2021 | Sale | $130.81 | 2,627 | 343,627 | 104,796 | Mar 10, 2021, 04:10 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 09, 2021 | Sale | $131.09 | 3,524 | 461,961 | 101,272 | Mar 10, 2021, 04:10 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 05, 2021 | Option Exercise | $37.68 | 18,537 | 698,469 | 111,973 | Mar 09, 2021, 04:17 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 03, 2021 | Sale | $150.78 | 2,174 | 327,796 | 100,644 | Mar 05, 2021, 05:43 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 04, 2021 | Sale | $137.55 | 2,658 | 365,619 | 97,986 | Mar 05, 2021, 05:43 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 02, 2021 | Sale | $152.05 | 912 | 138,672 | 91,932 | Mar 04, 2021, 05:46 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 27, 2021 | Option Exercise | $149.10 | 3,086 | 460,123 | 92,844 | Mar 02, 2021, 12:00 AM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Oct 29, 2020 | Option Exercise | $10.13 | 30,468 | 308,588 | 89,758 | Oct 30, 2020, 04:08 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 09, 2020 | Sale | $85.41 | 28,321 | 2,418,881 | 71,165 | Sep 11, 2020, 04:19 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 02, 2020 | Sale | $85.01 | 4,200 | 357,054 | 98,786 | Sep 11, 2020, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Sep 02, 2020 | Buy | $85.01 | 4,200 | 357,054 | 98,786 | Sep 03, 2020, 04:37 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 03, 2020 | Sale | $76.41 | 1,669 | 127,522 | 103,066 | Aug 05, 2020, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 04, 2020 | Sale | $76.81 | 2,048 | 157,307 | 101,018 | Aug 05, 2020, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 31, 2020 | Option Exercise | $76.17 | 3,717 | 283,124 | 104,735 | Aug 03, 2020, 05:39 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 07, 2020 | Option Exercise | $50.40 | 325 | 16,382 | 101,018 | Jul 08, 2020, 04:25 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | May 05, 2020 | Sale | $62.20 | 1,149 | 71,468 | 100,693 | May 07, 2020, 04:48 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | May 01, 2020 | Option Exercise | $65.80 | 2,333 | 153,511 | 103,026 | May 05, 2020, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | May 04, 2020 | Sale | $60.08 | 1,184 | 71,134 | 101,842 | May 05, 2020, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 06, 2020 | Sale | $22.90 | 23,651 | 541,522 | 103,938 | Mar 10, 2020, 04:20 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 02, 2020 | Sale | $72.97 | 1,485 | 108,360 | 67,721 | Mar 05, 2020, 04:47 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 27, 2020 | Option Exercise | $79.45 | 3,086 | 245,183 | 70,807 | Mar 02, 2020, 05:22 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 28, 2020 | Sale | $72.21 | 1,601 | 115,616 | 69,206 | Mar 02, 2020, 05:22 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 25, 2020 | Sale | $81.16 | 5,067 | 411,217 | 75,653 | Feb 28, 2020, 04:41 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 26, 2020 | Sale | $79.39 | 7,932 | 629,725 | 73,553 | Feb 28, 2020, 04:41 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 24, 2020 | Option Exercise | $88.26 | 12,999 | 1,147,292 | 80,720 | Feb 26, 2020, 05:18 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Oct 24, 2019 | Option Exercise | $7.48 | 4,580 | 34,258 | 67,721 | Oct 28, 2019, 04:28 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 22, 2019 | Option Exercise | $97.80 | 13,835 | 1,353,063 | 63,141 | Aug 26, 2019, 04:39 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 02, 2019 | Sale | $85.23 | 1,813 | 154,522 | 76,976 | Aug 06, 2019, 04:43 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 31, 2019 | Option Exercise | $65.08 | 13,948 | 907,755 | 82,091 | Aug 02, 2019, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Aug 01, 2019 | Sale | $83.20 | 1,905 | 158,502 | 78,789 | Aug 02, 2019, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 26, 2019 | Sale | $48.59 | 25,000 | 1,214,833 | 89,476 | Jul 30, 2019, 03:57 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 18, 2019 | Option Exercise | $48.80 | 15,000 | 732,000 | 84,476 | Jul 22, 2019, 10:47 AM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 05, 2019 | Option Exercise | $27.81 | 764 | 21,248 | 76,976 | Jul 09, 2019, 04:26 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jun 27, 2019 | Sale | $60.30 | 11,175 | 673,852 | 65,037 | Jun 28, 2019, 06:55 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jun 19, 2019 | Option Exercise | $35.93 | 25,000 | 898,125 | 88,712 | Jun 21, 2019, 04:06 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jun 10, 2019 | Sale | $55.05 | 1,130 | 62,212 | 76,272 | Jun 12, 2019, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | May 01, 2019 | Option Exercise | $44.07 | 2,334 | 102,859 | 78,546 | May 03, 2019, 04:15 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | May 02, 2019 | Sale | $43.79 | 1,204 | 52,729 | 77,342 | May 03, 2019, 04:15 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 28, 2019 | Option Exercise | $6.80 | 32,521 | 221,291 | 76,212 | Apr 01, 2019, 04:15 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Mar 01, 2019 | Sale | $34.70 | 81,172 | 2,816,507 | 42,136 | Mar 04, 2019, 04:13 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 28, 2019 | Sale | $53.68 | 1,558 | 83,633 | 25,239 | Mar 01, 2019, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 27, 2019 | Option Exercise | $52.90 | 3,087 | 163,302 | 26,797 | Mar 01, 2019, 04:32 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 22, 2019 | Option Exercise | $53.38 | 13,000 | 693,940 | 30,087 | Feb 26, 2019, 05:56 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Feb 25, 2019 | Sale | $53.63 | 6,377 | 341,986 | 23,710 | Feb 26, 2019, 05:56 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jan 16, 2019 | Sale | $30.28 | 50,000 | 1,513,825 | 29,587 | Jan 18, 2019, 04:17 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jan 11, 2019 | Sale | $27.22 | 52,502 | 1,428,949 | 34,587 | Jan 14, 2019, 04:35 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jan 09, 2019 | Sale | $27.19 | 17,976 | 488,708 | 26,075 | Jan 11, 2019, 04:16 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Dec 12, 2018 | Sale | $21.67 | 77,562 | 1,680,856 | 39,619 | Dec 13, 2018, 05:27 PM | |
NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Officer | Jul 06, 2018 | Option Exercise | $17.25 | 1,231 | 21,241 | 5,231 | Jul 10, 2018, 04:14 PM |